Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder Article Swipe
Diego Novick
,
William Montgomery
,
Tamás Treuer
,
Ai Koyanagi
,
Jaume Aguado
,
Susanne A. Kraemer
,
Josep María Haro
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.2147/ppa.s124581
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.2147/ppa.s124581
Nonadherent patients with schizophrenia or bipolar disorder treated with the orodispersible formulation were less likely to be hospitalized or suffer relapse compared to those patients taking the standard oral coated tablets.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2147/ppa.s124581
- https://www.dovepress.com/getfile.php?fileID=36808
- OA Status
- gold
- Cited By
- 15
- References
- 20
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2622997472
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2622997472Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2147/ppa.s124581Digital Object Identifier
- Title
-
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorderWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-06-01Full publication date if available
- Authors
-
Diego Novick, William Montgomery, Tamás Treuer, Ai Koyanagi, Jaume Aguado, Susanne A. Kraemer, Josep María HaroList of authors in order
- Landing page
-
https://doi.org/10.2147/ppa.s124581Publisher landing page
- PDF URL
-
https://www.dovepress.com/getfile.php?fileID=36808Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.dovepress.com/getfile.php?fileID=36808Direct OA link when available
- Concepts
-
Medicine, Olanzapine, Confidence interval, Odds ratio, Bipolar disorder, Schizophrenia (object-oriented programming), Internal medicine, Confounding, Logistic regression, Clinical Global Impression, Psychiatry, Observational study, Lithium (medication), Alternative medicine, Placebo, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
15Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 4, 2023: 1, 2022: 1, 2021: 4Per-year citation counts (last 5 years)
- References (count)
-
20Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2622997472 |
|---|---|
| doi | https://doi.org/10.2147/ppa.s124581 |
| ids.doi | https://doi.org/10.2147/ppa.s124581 |
| ids.mag | 2622997472 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28652711 |
| ids.openalex | https://openalex.org/W2622997472 |
| fwci | 0.88934335 |
| type | article |
| title | Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder |
| biblio.issue | |
| biblio.volume | Volume 11 |
| biblio.last_page | 1025 |
| biblio.first_page | 1019 |
| topics[0].id | https://openalex.org/T10854 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2738 |
| topics[0].subfield.display_name | Psychiatry and Mental health |
| topics[0].display_name | Bipolar Disorder and Treatment |
| topics[1].id | https://openalex.org/T10023 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9990000128746033 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2738 |
| topics[1].subfield.display_name | Psychiatry and Mental health |
| topics[1].display_name | Schizophrenia research and treatment |
| topics[2].id | https://openalex.org/T12547 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9979000091552734 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2735 |
| topics[2].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[2].display_name | Pharmaceutical studies and practices |
| funders[0].id | https://openalex.org/F4320307758 |
| funders[0].ror | https://ror.org/01qat3289 |
| funders[0].display_name | Eli Lilly and Company |
| is_xpac | False |
| apc_list.value | 2836 |
| apc_list.currency | USD |
| apc_list.value_usd | 2836 |
| apc_paid.value | 2836 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2836 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8920215368270874 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776619155 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7534645199775696 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q201872 |
| concepts[1].display_name | Olanzapine |
| concepts[2].id | https://openalex.org/C44249647 |
| concepts[2].level | 2 |
| concepts[2].score | 0.733401894569397 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[2].display_name | Confidence interval |
| concepts[3].id | https://openalex.org/C156957248 |
| concepts[3].level | 2 |
| concepts[3].score | 0.7152645587921143 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1862216 |
| concepts[3].display_name | Odds ratio |
| concepts[4].id | https://openalex.org/C2776174506 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6754168272018433 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q131755 |
| concepts[4].display_name | Bipolar disorder |
| concepts[5].id | https://openalex.org/C2776412080 |
| concepts[5].level | 2 |
| concepts[5].score | 0.6396285891532898 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7431605 |
| concepts[5].display_name | Schizophrenia (object-oriented programming) |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5935561060905457 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C77350462 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5633547306060791 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1125472 |
| concepts[7].display_name | Confounding |
| concepts[8].id | https://openalex.org/C151956035 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4915867745876312 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1132755 |
| concepts[8].display_name | Logistic regression |
| concepts[9].id | https://openalex.org/C2776000289 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4753941297531128 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q5133761 |
| concepts[9].display_name | Clinical Global Impression |
| concepts[10].id | https://openalex.org/C118552586 |
| concepts[10].level | 1 |
| concepts[10].score | 0.4215313792228699 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[10].display_name | Psychiatry |
| concepts[11].id | https://openalex.org/C23131810 |
| concepts[11].level | 2 |
| concepts[11].score | 0.4199787378311157 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q818574 |
| concepts[11].display_name | Observational study |
| concepts[12].id | https://openalex.org/C2778541603 |
| concepts[12].level | 2 |
| concepts[12].score | 0.10112729668617249 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q152763 |
| concepts[12].display_name | Lithium (medication) |
| concepts[13].id | https://openalex.org/C204787440 |
| concepts[13].level | 2 |
| concepts[13].score | 0.07333225011825562 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[13].display_name | Alternative medicine |
| concepts[14].id | https://openalex.org/C27081682 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[14].display_name | Placebo |
| concepts[15].id | https://openalex.org/C142724271 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[15].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8920215368270874 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/olanzapine |
| keywords[1].score | 0.7534645199775696 |
| keywords[1].display_name | Olanzapine |
| keywords[2].id | https://openalex.org/keywords/confidence-interval |
| keywords[2].score | 0.733401894569397 |
| keywords[2].display_name | Confidence interval |
| keywords[3].id | https://openalex.org/keywords/odds-ratio |
| keywords[3].score | 0.7152645587921143 |
| keywords[3].display_name | Odds ratio |
| keywords[4].id | https://openalex.org/keywords/bipolar-disorder |
| keywords[4].score | 0.6754168272018433 |
| keywords[4].display_name | Bipolar disorder |
| keywords[5].id | https://openalex.org/keywords/schizophrenia |
| keywords[5].score | 0.6396285891532898 |
| keywords[5].display_name | Schizophrenia (object-oriented programming) |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5935561060905457 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/confounding |
| keywords[7].score | 0.5633547306060791 |
| keywords[7].display_name | Confounding |
| keywords[8].id | https://openalex.org/keywords/logistic-regression |
| keywords[8].score | 0.4915867745876312 |
| keywords[8].display_name | Logistic regression |
| keywords[9].id | https://openalex.org/keywords/clinical-global-impression |
| keywords[9].score | 0.4753941297531128 |
| keywords[9].display_name | Clinical Global Impression |
| keywords[10].id | https://openalex.org/keywords/psychiatry |
| keywords[10].score | 0.4215313792228699 |
| keywords[10].display_name | Psychiatry |
| keywords[11].id | https://openalex.org/keywords/observational-study |
| keywords[11].score | 0.4199787378311157 |
| keywords[11].display_name | Observational study |
| keywords[12].id | https://openalex.org/keywords/lithium |
| keywords[12].score | 0.10112729668617249 |
| keywords[12].display_name | Lithium (medication) |
| keywords[13].id | https://openalex.org/keywords/alternative-medicine |
| keywords[13].score | 0.07333225011825562 |
| keywords[13].display_name | Alternative medicine |
| language | en |
| locations[0].id | doi:10.2147/ppa.s124581 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S66639021 |
| locations[0].source.issn | 1177-889X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1177-889X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Patient Preference and Adherence |
| locations[0].source.host_organization | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_name | Dove Medical Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_lineage_names | Dove Medical Press |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://www.dovepress.com/getfile.php?fileID=36808 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Patient Preference and Adherence |
| locations[0].landing_page_url | https://doi.org/10.2147/ppa.s124581 |
| locations[1].id | pmid:28652711 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Patient preference and adherence |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28652711 |
| locations[2].id | pmh:oai:doaj.org/article:ed0c4aee490640f18b7640290271d3cb |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Patient Preference and Adherence, Vol Volume 11, Pp 1019-1025 (2017) |
| locations[2].landing_page_url | https://doaj.org/article/ed0c4aee490640f18b7640290271d3cb |
| locations[3].id | pmh:oai:europepmc.org:4329508 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | http://europepmc.org/articles/PMC5476712 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:5476712 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Patient Prefer Adherence |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5476712 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5107876782 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Diego Novick |
| authorships[0].affiliations[0].raw_affiliation_string | global Patient Outcomes and real World evidence (gPOrWe), eli lilly and company, Windlesham, surrey, UK; |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Diego Novick |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | global Patient Outcomes and real World evidence (gPOrWe), eli lilly and company, Windlesham, surrey, UK; |
| authorships[1].author.id | https://openalex.org/A5113737001 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | William Montgomery |
| authorships[1].countries | AU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800535057 |
| authorships[1].affiliations[0].raw_affiliation_string | global Patient Outcomes and real World evidence (gPOrWe), eli lilly Australia Pty ltd, West ryde, Australia; |
| authorships[1].institutions[0].id | https://openalex.org/I2800535057 |
| authorships[1].institutions[0].ror | https://ror.org/014vqg108 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I2800535057, https://openalex.org/I2801453606, https://openalex.org/I4387156119 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | IP Australia |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | William Montgomery |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | global Patient Outcomes and real World evidence (gPOrWe), eli lilly Australia Pty ltd, West ryde, Australia; |
| authorships[2].author.id | https://openalex.org/A5111645037 |
| authorships[2].author.orcid | https://orcid.org/0009-0007-0798-3942 |
| authorships[2].author.display_name | Tamás Treuer |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I168537998 |
| authorships[2].affiliations[0].raw_affiliation_string | global Patient Outcomes and real World evidence (gPOrWe), eli lilly and company, Budapest, hungary; |
| authorships[2].institutions[0].id | https://openalex.org/I168537998 |
| authorships[2].institutions[0].ror | https://ror.org/01qat3289 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I168537998 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Eli Lilly (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Tamas Treuer |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | global Patient Outcomes and real World evidence (gPOrWe), eli lilly and company, Budapest, hungary; |
| authorships[3].author.id | https://openalex.org/A5047608893 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9565-5004 |
| authorships[3].author.display_name | Ai Koyanagi |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210128981, https://openalex.org/I71999127 |
| authorships[3].affiliations[0].raw_affiliation_string | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| authorships[3].institutions[0].id | https://openalex.org/I4210128981 |
| authorships[3].institutions[0].ror | https://ror.org/02f3ts956 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210128981 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Parc Sanitari Sant Joan de Déu |
| authorships[3].institutions[1].id | https://openalex.org/I71999127 |
| authorships[3].institutions[1].ror | https://ror.org/021018s57 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I71999127 |
| authorships[3].institutions[1].country_code | ES |
| authorships[3].institutions[1].display_name | Universitat de Barcelona |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | A Koyanagi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| authorships[4].author.id | https://openalex.org/A5082724011 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9575-0212 |
| authorships[4].author.display_name | Jaume Aguado |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210128981, https://openalex.org/I71999127 |
| authorships[4].affiliations[0].raw_affiliation_string | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| authorships[4].institutions[0].id | https://openalex.org/I4210128981 |
| authorships[4].institutions[0].ror | https://ror.org/02f3ts956 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210128981 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Parc Sanitari Sant Joan de Déu |
| authorships[4].institutions[1].id | https://openalex.org/I71999127 |
| authorships[4].institutions[1].ror | https://ror.org/021018s57 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I71999127 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Universitat de Barcelona |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jaume Aguado |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| authorships[5].author.id | https://openalex.org/A5007352854 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9202-5333 |
| authorships[5].author.display_name | Susanne A. Kraemer |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210110958 |
| authorships[5].affiliations[0].raw_affiliation_string | Medical Department, eli lilly and company, Bad homburg, germany |
| authorships[5].institutions[0].id | https://openalex.org/I4210110958 |
| authorships[5].institutions[0].ror | https://ror.org/01pmvz131 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I168537998, https://openalex.org/I4210110958 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | Eli Lilly (Germany) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Susanne Kraemer |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Medical Department, eli lilly and company, Bad homburg, germany |
| authorships[6].author.id | https://openalex.org/A5030573483 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3984-277X |
| authorships[6].author.display_name | Josep María Haro |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210128981, https://openalex.org/I71999127 |
| authorships[6].affiliations[0].raw_affiliation_string | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| authorships[6].institutions[0].id | https://openalex.org/I4210128981 |
| authorships[6].institutions[0].ror | https://ror.org/02f3ts956 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210128981 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Parc Sanitari Sant Joan de Déu |
| authorships[6].institutions[1].id | https://openalex.org/I71999127 |
| authorships[6].institutions[1].ror | https://ror.org/021018s57 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I71999127 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Universitat de Barcelona |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Josep Maria Haro |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Parc sanitari sant Joan de Déu, ciBersAM, Universitat de Barcelona, Barcelona, spain; |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.dovepress.com/getfile.php?fileID=36808 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10854 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2738 |
| primary_topic.subfield.display_name | Psychiatry and Mental health |
| primary_topic.display_name | Bipolar Disorder and Treatment |
| related_works | https://openalex.org/W2898752671, https://openalex.org/W2101541124, https://openalex.org/W2108022657, https://openalex.org/W2467738672, https://openalex.org/W2381725564, https://openalex.org/W2006590030, https://openalex.org/W1525279136, https://openalex.org/W1981207331, https://openalex.org/W2094817135, https://openalex.org/W2473143693 |
| cited_by_count | 15 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 4 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 1 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 2 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 1 |
| locations_count | 5 |
| best_oa_location.id | doi:10.2147/ppa.s124581 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S66639021 |
| best_oa_location.source.issn | 1177-889X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1177-889X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Patient Preference and Adherence |
| best_oa_location.source.host_organization | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_name | Dove Medical Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_lineage_names | Dove Medical Press |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=36808 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Patient Preference and Adherence |
| best_oa_location.landing_page_url | https://doi.org/10.2147/ppa.s124581 |
| primary_location.id | doi:10.2147/ppa.s124581 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S66639021 |
| primary_location.source.issn | 1177-889X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1177-889X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Patient Preference and Adherence |
| primary_location.source.host_organization | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_name | Dove Medical Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_lineage_names | Dove Medical Press |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=36808 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Patient Preference and Adherence |
| primary_location.landing_page_url | https://doi.org/10.2147/ppa.s124581 |
| publication_date | 2017-06-01 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2003289380, https://openalex.org/W2078288632, https://openalex.org/W2111302567, https://openalex.org/W2330456179, https://openalex.org/W1807166034, https://openalex.org/W2048187664, https://openalex.org/W1907262344, https://openalex.org/W2027235889, https://openalex.org/W2189277541, https://openalex.org/W2138418531, https://openalex.org/W1966865495, https://openalex.org/W2145909170, https://openalex.org/W2030034545, https://openalex.org/W1551899259, https://openalex.org/W1991044306, https://openalex.org/W2088662128, https://openalex.org/W2158220477, https://openalex.org/W2078404387, https://openalex.org/W2068456588, https://openalex.org/W2135664575 |
| referenced_works_count | 20 |
| abstract_inverted_index.be | 16 |
| abstract_inverted_index.or | 4, 18 |
| abstract_inverted_index.to | 15, 22 |
| abstract_inverted_index.the | 9, 26 |
| abstract_inverted_index.less | 13 |
| abstract_inverted_index.oral | 28 |
| abstract_inverted_index.were | 12 |
| abstract_inverted_index.with | 2, 8 |
| abstract_inverted_index.those | 23 |
| abstract_inverted_index.coated | 29 |
| abstract_inverted_index.likely | 14 |
| abstract_inverted_index.suffer | 19 |
| abstract_inverted_index.taking | 25 |
| abstract_inverted_index.bipolar | 5 |
| abstract_inverted_index.relapse | 20 |
| abstract_inverted_index.treated | 7 |
| abstract_inverted_index.compared | 21 |
| abstract_inverted_index.disorder | 6 |
| abstract_inverted_index.patients | 1, 24 |
| abstract_inverted_index.standard | 27 |
| abstract_inverted_index.tablets. | 30 |
| abstract_inverted_index.Nonadherent | 0 |
| abstract_inverted_index.formulation | 11 |
| abstract_inverted_index.hospitalized | 17 |
| abstract_inverted_index.schizophrenia | 3 |
| abstract_inverted_index.orodispersible | 10 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 4 |
| institutions_distinct_count | 7 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.4699999988079071 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.69763373 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |